Overexpression of SLC7A11 has been reported in various cancers, including lung, breast, and ovarian cancers, where it contributes to tumor growth, chemoresistance, and poor prognosis (Liu et al., 2020). The gene discussed is SLC7A11; the disease is ovarian cancer.